Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-08-25
1988-08-16
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 68, A61K 3148, C07D45712
Patent
active
047645172
ABSTRACT:
A compound of formula I ##STR1## wherein R.sub.1 is n-propyl,
REFERENCES:
patent: 4180582 (1979-12-01), Kornfeld et al.
patent: 4202279 (1980-05-01), Kornfeld et al.
patent: 4348391 (1982-09-01), Stutz et al.
patent: 4348392 (1982-09-01), Fehr et al.
patent: 4379790 (1983-04-01), Horowski et al.
Clemens et al., Chemical Regulation of Biological Mechanisms, pp. 167-180.
Fuller et al., Neuroendocrinology 36, 285-290, 1983.
Fuller et al., Endocrinolgy, vol. 109, No. 4, pp. 1026-1032, (1981).
Lemberger et al., Science, vol. 205, (1979), p. 1151.
Clemens et al., IRCS Medical Science: Biochemistry; Nervous System; Pharmacology; Psychology and Psychiatry 6, 427.
Nakamura et al., Communication in Psychopharmacology, vol. 3, pp. 179-183, (1979).
Gerstl Robert
Honor Robert S.
McGovern Thomas O.
Sandoz Ltd.
Sharkin Gerald D.
LandOfFree
8.alpha.-(N,N-diethylsulfamoylamino)-6-n-propyl ergoline useful does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8.alpha.-(N,N-diethylsulfamoylamino)-6-n-propyl ergoline useful , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8.alpha.-(N,N-diethylsulfamoylamino)-6-n-propyl ergoline useful will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-600751